Bordeaux, France, December 8, 2022 – FineHeart S.A, a medical device company developing the ICOMS FLOWMAKER®, a fully implantable cardiac output restoration system to address the unmet needs of patients suffering from severe heart failure, announced today that it has been awarded €1.5M in funding from the European ERDF/ESF program. This program supports the European Regional Development Fund and the European Social Fund “Investment for growth and employment in the New Aquitaine Region”.

FineHeart receives ANSM authorization for French clinical study